BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Shape Therapeutics

Shape Therapeutics logo

United States of America based

Shape Therapeutics (ShapeTx) is a development-stage biotechnology company establishing itself as the leader in next-generation gene therapy. Our novel technology platform enables direct in vivo targeting/modification of RNA by leveraging ADARs (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and immune-stealth adeno-associated viruses (AAVs).

ShapeTx is providing solutions to many of the challenges that contemporary genome engineering technologies face (like CRISPR, TALENs, etc.), such as permanent off-target damage, high risk of immunogenicity and therefore low in vivo applicability as effective gene therapy approaches. ShapeTx’s technology instead engages natural human cellular machinery to target RNA with high in vivo efficiency.


CRISPR Startups   Gene Therapy Startups   RNA-focused Startups  

Posts Mentioning This Company

Biopharma Insights
Biopharma Insights

R&D Platform


No pipelines published yet




No services posted yet